Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer.
Ilaria Grazia ZizzariAlessandra Di FilippoAndrea BotticelliLidia StrigariAngelina PernazzaEmma RulloMaria Gemma PignataroAlessio UgoliniFabio ScirocchiFrancesca Romana Di PietroErnesto RossiAlain J GelibterGiovanni SchinzariGiulia d'AmatiAurelia RughettiMarina Chiara GarassinoMarianna NutiChiara NapoletanoPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
We propose the CD137+ T subset as an immune biomarker to define the wellness status of the immune system for successful anticancer immunotherapy.
Keyphrases